We aimed to identify mechanisms of immune checkpoint inhibitor associated neurological immune related adverse events (irAE) by studying their immune cell composition.
No takes yet. Share an insight, caveat, or question.
Müller‐Miny et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: